Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Flagship Pioneering Expands into Asia-Pacific Region, with Regional Hub in Singapore
2023-11-08 06:00
Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer
2023-11-08 02:01
Discovery Life Sciences Announces New CEO
2023-11-07 23:01
Nuevocor presents pre-clinical data at ESGCT and AHA meetings
2023-11-07 22:00
Turn Biotechnologies First to Deliver mRNA into the Dermis Using Proprietary LNPs, With No Distribution to Other Organs
2023-11-07 21:30
Kexing Biopharm Attended CPHI Worldwide 2023
2023-11-07 20:09
Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis Demonstrating Strong Overall Survival Benefit as First-line Treatment in All-comer Patients with Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC)
2023-11-07 20:00
Xinhua Silk Road: E. China's Quanzhou: cheering up the power of technological innovation
2023-11-07 16:39
First Mover of Global Trade Index Based On Biome Molecule, Kwanyoung Park of AndKwan Natural Science
2023-11-07 15:47
BioRay Announces First-Patient-In for Phase I Clinical Study of BRY812, a Novel LIV-1 Targeting Antibody Drug Conjugate
2023-11-07 14:14
87.5% ORR | Abbisko presented two clinical updates of Pimicotinib at the 2023 CTOS Annual Meeting
2023-11-07 12:31
2023 World Laureates Association Prize winners awarded in Shanghai
2023-11-07 09:49
Clover Completes BLA Submission for Seasonal Influenza Vaccine in Brazil
2023-11-07 08:00
Lerna Bio unveils its first-in-class solution to combat liver failure
2023-11-06 22:00
I-Mab Announces Participation at Jefferies and Piper Conferences in November
2023-11-06 21:00
Biotheus Enters Into Strategic Partnership with BioNTech to Develop and Commercialize Bispecific Antibody Candidate Targeting PD-L1 and VEGF in Multiple Solid Tumor Indications
2023-11-06 20:00
Novogene AMEA adopts Olink® Explore HT platform
2023-11-06 18:00
L'Oréal Announces North Asia Big Bang Beauty Tech Innovation Program Winners with Innovation Showcase at China International Import Expo
2023-11-06 15:00
Gannex Published Phase I Data of ASC42, a Novel Farnesoid X Receptor Agonist on the Journal Drugs in R&D
2023-11-06 12:20
The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval
2023-11-06 09:11
1
70
71
72
73
74
451